Cencora's MWI Animal Health Merger With Covetrus Sees 'Intensified' FTC Scrutiny, RBC Says

MT Newswires Live00:02

Cencora's (COR) MWI Animal Health's pending merger with Covetrus sees "intensified" Federal Trade Commission scrutiny, RBC Capital Markets said, noting that the combined entity is expected to hold 67% to 75% of the US veterinary distribution market.

The FTC issued Civil Investigative Demands to all parties in July and raised a second request under the Hart-Scott-Rodino Act earlier in May, RBC said in a note Friday.

RBC said that a key question is if the agency defines the relevant market as companion and production animals or just companion animals, which will materially impact the estimated concentration levels.

The firm said it now expects 2027 revenue of $351.37 billion and EPS of $19.50 from $354.74 billion and $19.76 previously, accounting for the transaction closing and removing MWI Animal Health from the estimates.

RBC maintained the company's sector perform rating and $330 price target.

Price: 324.59, Change: -6.36, Percent Change: -1.92

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment